Eosinophils from healthy children (1-3 years) and adults express high levels of prostaglandin D2 receptor 2 (DP2)
V. Erpenbeck (Basel, Switzerland), P. Groh (Cincinnati, United States of America), K. Curtsinger (Cincinnati, United States of America), C. Sarah (Cambridge, United States of America), I. Jones (Basel, Switzerland), S. Machineni (Hyderabad, India), M. Cabanski (Basel, Switzerland), A. Vitaliti (Basel, Switzerland), Y. Pluess-Li (Basel, Switzerland), A. Verles (Basel, Switzerland), B. Dharmalingam (Hyderabad, India), G. Hershey (Cincinnati, United States of America)
Source: International Congress 2018 – Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Erpenbeck (Basel, Switzerland), P. Groh (Cincinnati, United States of America), K. Curtsinger (Cincinnati, United States of America), C. Sarah (Cambridge, United States of America), I. Jones (Basel, Switzerland), S. Machineni (Hyderabad, India), M. Cabanski (Basel, Switzerland), A. Vitaliti (Basel, Switzerland), Y. Pluess-Li (Basel, Switzerland), A. Verles (Basel, Switzerland), B. Dharmalingam (Hyderabad, India), G. Hershey (Cincinnati, United States of America). Eosinophils from healthy children (1-3 years) and adults express high levels of prostaglandin D2 receptor 2 (DP2). 4456
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
BMS-986278, a lysophosphatidic acid 1 (LPA1) receptor antagonist, in healthy participants: A single/multiple ascending dose (SAD/MAD) phase 1 study Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment Year: 2019
GB001, a selective prostaglandin D2 receptor 2 antagonist, blocks signaling in the peripheral blood of healthy subjects Source: Virtual Congress 2020 – Clinical and laboratory pharmacology in asthma Year: 2020
Glucocorticosteroid receptor (GCR) gene isoforms expression in bronchial asthma (BA) patients Source: Annual Congress 2011 - Asthma: a heterogeneous disease Year: 2011
Thromboxane B2 (TXB2) urine levels during long term treatment with montelukast (M) in asthmatic subjects Source: Eur Respir J 2001; 18: Suppl. 33, 353s Year: 2001
Prevalence of asthma and atopic states-related symptoms in school (6-7 yrs), high school (13-14 yrs) children in Tabriz (ISAAC study) Source: Eur Respir J 2001; 18: Suppl. 33, 368s Year: 2001
Deletion in macrophage chemokine receptor gene (CCR5) in children with bronchial asthma (BA) Source: Eur Respir J 2001; 18: Suppl. 33, 450s Year: 2001
High affinity receptor for immunoglobulin E (FcER1-β) gene polymorphisms in Turkish allergic asthmatic subgroups Source: Annual Congress 2009 - Genetics of lung diseases Year: 2009
Expression on peripheral blood (PB) and induced sputum (IS) neutrophils (N) of the IL-8 receptors CXCR1 and CXCR2. Comparison between neutrophilic asthma and COPD Source: Annual Congress 2003 - From gene to breath analysis in airway disorders Year: 2003
Expression of glucocorticoid receptor beta (GCRβ) in asthmatic children and its correlation with clinical severity Source: Eur Respir J 2004; 24: Suppl. 48, 162s Year: 2004
Mas receptor antagonist inhibits the pro-resolutive effects of Angiotensin-(1-7) in an experimental model of asthma. Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019
Increased expression of the cysteinil leukotriene 1 receptor (CysLT1-R) in the bronchial epithelium of smokers Source: Eur Respir J 2001; 18: Suppl. 33, 74s Year: 2001
Lung function parameters in healthy Lybian children (aged 4-19 years) Source: Eur Respir J 2005; 26: Suppl. 49, 612s Year: 2005
Validation of the asthma control questionnaire in children (6-16 years) Source: Annual Congress 2009 - Clinical advances in childhood asthma Year: 2009
Pneumonia severity index (PSI) at young patients and toll-like receptor 4 (TLR4) polymorphism interconnections: new diagnostic approach Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases Year: 2019
Does beta2 adrenoceptor (ADRβ2) density vary in circulating lymphyocytes compared with monocytes? Source: Annual Congress 2011 - Lung development and neoplasia Year: 2011
Distinct effects of the endothelin receptor antagonists PD 142893 (ET-A/B), BQ 788 (ET-B) and N-Ac-Trp-ET 1 Frg. 16-21 (ET-A) on oxidative stress-induced pulmonary hypertension in isolated rabbit lungs Source: Eur Respir J 2001; 18: Suppl. 33, 198s Year: 2001
Cytokines and alpha-1proteinase inhibitor (A1 PI) levels in meat wrappers‘ asthma Source: Annual Congress 2010 - Occupational asthma Year: 2010
Diagnostic value of serum soluble interleukin-2 receptor (SIL- 2R) and acute phase proteins levels (APP) in community acquired pneumonia Source: Eur Respir J 2003; 22: Suppl. 45, 149s Year: 2003
PBF-680, an oral A1 adenosine receptor antagonist, inhibits the late allergic response (LAR) in mild-to-moderate atopic asthmatics: a Phase-IIa trial Source: Virtual Congress 2020 – Cutting edge science: novel molecules and mechanisms of airway diseases Year: 2020
Expression of transforming growth factor β (TGFβ) receptor, CD105, is declined in Th1 interstitial lung diseases (ILDs) Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011